Kadia, T. M., Reville, P. K., Borthakur, G., Yilmaz, M., Kornblau, S., Alvarado, Y., Dinardo, C. D., Daver, N., Jain, N., Pemmaraju, N., Short, N., Wang, S. A., Tidwell, R. S. S., Islam, R., Konopleva, M., Garcia-Manero, G., Ravandi, F., & Kantarjian, H. M. (2021). venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. Lancet, 8(8), e552–e561. http://access.bl.uk/ark:/81055/vdc_100136723067.0x000007